09:51 AM EST - Appili Therapeutics Inc. : Announced that Dr. Carl Gelhaus, Senior Program Manager of the Medical Countermeasures Division at MRIGlobal, will present positive interim data on Appili’s ATI-1701 program at the 2020 ASM Biothreats conference. Hosted by the American Society for Microbiology, the conference is being held from January 28–30, in Arlington, Virginia. Appili Therapeutics Inc.
shares V.APLI are trading unchanged at $0.88.
